BIOMAT Database Logo BIOMAT Database Logo

The synthesis and pharmacological properties of [2-isoleucine]-8-lysine-vasopressin and its 1-deamino analog. 1969

R T Havran, and V Du Vigneaud

UI MeSH Term Description Entries
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014667 Vasopressins Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure. Antidiuretic Hormone,Antidiuretic Hormones,beta-Hypophamine,Pitressin,Vasopressin,Vasopressin (USP),Hormone, Antidiuretic,beta Hypophamine
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

R T Havran, and V Du Vigneaud
Synthesis and pharmacological properties of 4-decarboxamido-8-arginine-vasopressin and its 1-deamino analog.
May 1970, Journal of medicinal chemistry,
R T Havran, and V Du Vigneaud
Synthesis and some of the pharmacological properties of (4-leucine)-8-lysine-vasopressin and (1-deamino,4-leucine)-8-lysine-vasopressin.
July 1973, Journal of medicinal chemistry,
R T Havran, and V Du Vigneaud
The synthesis and pharmacological properties of 4-decarboxamido-8-lysine-vasopressin, 5-decarboxamido-8-lysine-vasopressin, and their 1-deamino analogues.
October 1967, The Journal of biological chemistry,
R T Havran, and V Du Vigneaud
Synthesis and some pharmacological properties of 8-L-homoarginine-vasopressin and of 1-deamino-8-L-homoarginine-vasopressin.
July 1974, Journal of medicinal chemistry,
R T Havran, and V Du Vigneaud
Solid phase synthesis and some pharmacological properties of 8-D-homolysine-vasopressin and 1-deamino-8-D-homolysine-vasopressin.
January 1975, International journal of peptide and protein research,
R T Havran, and V Du Vigneaud
Solid phase synthesis and some pharmacological properties of 8-D-homoarginine-vasopressin and 1-deamino-8-D-homoarginine-vasopressin.
January 1976, International journal of peptide and protein research,
R T Havran, and V Du Vigneaud
Synthesis and properties of 1-deamino-8-L-homolysine-vasopressin.
June 1972, Journal of medicinal chemistry,
R T Havran, and V Du Vigneaud
Synthesis and some pharmacological properties of (1-alpha-mercaptoacetic acid)-8-lysine-vasopressin and (1-gamma-mercaptobutyric acid)-8-lysine-vasopressin.
November 1974, Journal of the American Chemical Society,
R T Havran, and V Du Vigneaud
Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
June 1976, Journal of medicinal chemistry,
R T Havran, and V Du Vigneaud
A COMPARISON OF THE EFFECTS OF 8-LYSINE-VASOPRESSIN, 1-DEAMINO-8-LYSINE-VASOPRESSIN AND 1-ACETYL-8-LYSINE-VASOPRESSIN ON THE BLOOD GLUCOSE LEVEL IN RABBITS.
May 1964, Endocrinology,
Copied contents to your clipboard!